Literature DB >> 2920847

Interrelationships among semen characteristics, antisperm antibodies, and cervical mucus penetration assays in infertile human couples.

A C Menge1, O Beitner.   

Abstract

Semen characteristics, antisperm antibodies, and cervical mucus penetration studies were analyzed in 754 couples and 95 men undergoing infertility evaluation. The means for the different semen/sperm variables were within ranges published for fertile men. Ages of the men ranged from 22 to 55 years and accounted for a small amount of variation. Sperm counts were lowest in September, December, and January, and highest in April, May, October, and November. Of the sperm characteristics, morphology appeared to be associated with the most other variables. Specimens with more than 50% abnormal sperm forms were overall of significantly poorer quality in terms of sperm counts, motility, forward progression, and ability to penetrate cervical mucus. Antisperm antibodies (agglutinating and immobilizing) were detected in the serum samples of 19.0% of the men, 20.4% of the women, and 32.8% of the couples where one or both partners were positive. Agglutinating antibody titers were significantly correlated between partners. Serum titers of antisperm antibodies were associated with decreased sperm counts, motility, forward progression, and normal forms (immobilizing antibodies). Multiple correlation analysis indicated significant independent effects of sperm concentration, motility, forward progression, and antibodies on sperm-cervical mucus penetration scores of the men. In women, cervical mucus penetration was adversely affected by the presence in the serum of sperm agglutinating antibodies and of immobilizing activity in the cervical mucus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920847     DOI: 10.1016/s0015-0282(16)60559-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  Influence of melatonin and photoperiod on animal and human reproduction.

Authors:  A Cagnacci; A Volpe
Journal:  J Endocrinol Invest       Date:  1996-06       Impact factor: 4.256

2.  Improvement in pregnancy outcomes in couples with immunologically male infertility undergoing prednisolone treatment and conventional in vitro fertilization preceded by sperm penetration assay: a randomized controlled trial.

Authors:  Ahmed M Taiyeb; Mundhir T Ridha-Albarzanchi; Shereen M Taiyeb; Zuhair A Kanan; Shahla K Alatrakchi; Michael E Kjelland; Saeeda A Muhsen-Alanssari
Journal:  Endocrine       Date:  2017-10-13       Impact factor: 3.633

3.  Can semen analysis predict the presence of antisperm antibodies in patients with primary infertility?

Authors:  M S Cookson; M A Witt; K T Kimball; J E Grantmyre; L I Lipshultz
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 4.  Antisperm antibodies and conception.

Authors:  L W Chamley; G N Clarke
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

5.  Validation of a laboratory-developed test of human sperm capacitation.

Authors:  Melissa A Moody; Cristina Cardona; Alana J Simpson; T Timothy Smith; Alexander J Travis; G Charles Ostermeier
Journal:  Mol Reprod Dev       Date:  2017-04-18       Impact factor: 2.609

Review 6.  Role of Antisperm Antibodies in Infertility, Pregnancy, and Potential forContraceptive and Antifertility Vaccine Designs: Research Progress and Pioneering Vision.

Authors:  Vickram A S; Kuldeep Dhama; Sandip Chakraborty; Hari Abdul Samad; Shyma K Latheef; Khan Sharun; Sandip Kumar Khurana; Archana K; Ruchi Tiwari; Prakash Bhatt; Vyshali K; Wanpen Chaicumpa
Journal:  Vaccines (Basel)       Date:  2019-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.